ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,308, issued on June 17, was assigned to IMPERIAL COLLEGE INNOVATIONS Ltd. (London).
"Phagemid vector" was invented by Amin Hajitou (London), Paladd Asavarut (London) and Teerapong Yata (London).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides hybrid and recombinant phagemid vectors for expressing a transgene in a target cell transduced with the vector. A recombinant phagemid particle comprises at least one transgene expression cassette which encodes an agent which exerts a biological effect on the target cell, characterised in that the phagemid particle comprises a genome which lacks at least 50% of its bacteriophage genome. The ...